Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
Episodes 31-45 of 149
A Patient-Centered Approach to Managing Anemia in Myelofibrosis
Project Oncology®A Patient-Centered Approach to Managing Anemia in Myelofibrosis
Understanding Anemia in Myelofibrosis: Multifactorial Origins and Management Strategies
Project Oncology®Understanding Anemia in Myelofibrosis: Multifactorial Origins and Management Strategies
Patient-Centered Insights for Advanced Prostate Cancer Treatment
On the Frontlines of Prostate CancerPatient-Centered Insights for Advanced Prostate Cancer Treatment
Exercise in Multiple Myeloma: Balancing Benefits and Safety
Project Oncology®Exercise in Multiple Myeloma: Balancing Benefits and Safety
Advances in Prostate Cancer Care: Genetic Testing, Teamwork, and ARPIs
On the Frontlines of Prostate CancerAdvances in Prostate Cancer Care: Genetic Testing, Teamwork, and ARPIs
mCRPC Care: Predicting Outcomes with a Novel Cell-Free DNA Sequencing Assay
On the Frontlines of Prostate CancermCRPC Care: Predicting Outcomes with a Novel Cell-Free DNA Sequencing Assay
Predictive Models for CAR T-Cell Therapy: Personalizing R/R LBCL Care
Project Oncology®Predictive Models for CAR T-Cell Therapy: Personalizing R/R LBCL Care
Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
Project Oncology®Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
Mastering CAR-T Cell Therapy in R/R Large B-Cell Lymphoma: Adverse Event Management
Project Oncology®Mastering CAR-T Cell Therapy in R/R Large B-Cell Lymphoma: Adverse Event Management
Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia
Project Oncology®Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia
Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings
On the Frontlines of Non-Small Cell Lung CancerTargeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings
Preventing Adverse Events in CAR T-Cell Therapy: The Evolution of Safety Protocols
Project Oncology®Preventing Adverse Events in CAR T-Cell Therapy: The Evolution of Safety Protocols
